Skip to main content
Erschienen in: Journal of Genetic Counseling 4/2012

01.08.2012 | Original Research

What Information Do Cancer Genetic Counselees Prioritize?

verfasst von: Afsaneh Hayat Roshanai, Claudia Lampic, Charlotta Ingvoldstad, Marie Stenmark Askmalm, Chathrine Bjorvatn, Richard Rosenquist, Karin Nordin

Erschienen in: Journal of Genetic Counseling | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

This study explored the informational needs of individuals attending genetic counseling for hereditary cancer, using a free-choice and a forced choice method. Prior to the consultation the informational needs of 334 counselees from Sweden and Norway were assessed by the QUOTE-gene (ca) questionnaire and by a study specific forced choice method, using Q-methodology. Questionnaire responses indicated that counselees’ major concerns pertained to the need to be taken seriously, to be provided with sufficient risk estimation and medical/genetic information and to be involved in the decision making process. Furthermore, prior to counseling, counselees noted that the counselors’ consideration and skillfulness were also extremely important. Analysis of the Q-sorting results revealed that counselees’ needs could be assigned to one of five groups: the “need for facts; caring communication and medical information; information and support in communicating the genetic information to others; practical care and practical/medical information”. Particularly noteworthy, counselees with varying backgrounds characteristics prioritized different needs. Cancer genetic counselees probably have different needs due to their medical and demographic background when attending genetic counseling. Addressing counselees’ specific concerns more sufficiently and thereby increasing the overall effectiveness of the counseling session requires increased insight into individual needs, by for instance, utilizing screening methods such as QUOTE-gene (ca) prior to the counseling session.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
Quality of Care Through the Patient’s Eyes
 
2
Other factor solutions were examined, but this solution appeared to be most sufficient.
 
3
The numbers in the parentheses refer to the statement numbers written on Q-cards.
 
Literatur
Zurück zum Zitat Act. (2003-12-05). Act regarding human medical use of biotechnology. Norwegian legislation. Act. (2003-12-05). Act regarding human medical use of biotechnology. Norwegian legislation.
Zurück zum Zitat Albada, A., Ausems, M. G., Bensing, J. M., & van Dulmen, S. (2009a). Tailored information about cancer risk and screening: a systematic review. Patient Education and Counseling, 77(2), 155–171.CrossRef Albada, A., Ausems, M. G., Bensing, J. M., & van Dulmen, S. (2009a). Tailored information about cancer risk and screening: a systematic review. Patient Education and Counseling, 77(2), 155–171.CrossRef
Zurück zum Zitat Albada, A., van Dulmen, S., Otten, R., Bensing, J. M., & Ausems, M. G. (2009b). Development of E-info gene(ca): a website providing computer-tailored information and question prompt prior to breast cancer genetic counseling. Journal of Genetic Counseling, 18(4), 326–338.CrossRef Albada, A., van Dulmen, S., Otten, R., Bensing, J. M., & Ausems, M. G. (2009b). Development of E-info gene(ca): a website providing computer-tailored information and question prompt prior to breast cancer genetic counseling. Journal of Genetic Counseling, 18(4), 326–338.CrossRef
Zurück zum Zitat Baile, W. F., & Aaron, J. (2005). Patient-physician communication in oncology: past, present, and future. Current Opinion in Oncology, 17(4), 331–335.PubMedCrossRef Baile, W. F., & Aaron, J. (2005). Patient-physician communication in oncology: past, present, and future. Current Opinion in Oncology, 17(4), 331–335.PubMedCrossRef
Zurück zum Zitat Bjorvatn, C., Eide, G. E., Hanestad, B. R., Oyen, N., Havik, O. E., Carlsson, A., et al. (2007). Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. Journal of Genetic Counseling, 16(2), 211–222.PubMedCrossRef Bjorvatn, C., Eide, G. E., Hanestad, B. R., Oyen, N., Havik, O. E., Carlsson, A., et al. (2007). Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. Journal of Genetic Counseling, 16(2), 211–222.PubMedCrossRef
Zurück zum Zitat Collins, V., Halliday, J., Warren, R., & Williamson, R. (2000). Assessment of education and counselling offered by a familial colorectal cancer clinic. Clinical Genetics, 57(1), 48–55.PubMedCrossRef Collins, V., Halliday, J., Warren, R., & Williamson, R. (2000). Assessment of education and counselling offered by a familial colorectal cancer clinic. Clinical Genetics, 57(1), 48–55.PubMedCrossRef
Zurück zum Zitat Fagerlind, H., Lindblad, A. K., Bergstrom, I., Nilsson, M., Naucler, G., Glimelius, B., et al. (2008). Patient-physician communication during oncology consultations. Psycho-Oncology, 17(10), 975–985.PubMedCrossRef Fagerlind, H., Lindblad, A. K., Bergstrom, I., Nilsson, M., Naucler, G., Glimelius, B., et al. (2008). Patient-physician communication during oncology consultations. Psycho-Oncology, 17(10), 975–985.PubMedCrossRef
Zurück zum Zitat Hallowell, N., Murton, F., Statham, H., Green, J. M., & Richards, M. P. (1997). Women’s need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study. BMJ, 314(7076), 281–283.PubMedCrossRef Hallowell, N., Murton, F., Statham, H., Green, J. M., & Richards, M. P. (1997). Women’s need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study. BMJ, 314(7076), 281–283.PubMedCrossRef
Zurück zum Zitat Holloway, S., Porteous, M., Cetnarskyj, R., Anderson, E., Rush, R., Fry, A., et al. (2004). Patient satisfaction with two different models of cancer genetic services in south-east Scotland. British Journal of Cancer, 90(3), 582–589.PubMedCrossRef Holloway, S., Porteous, M., Cetnarskyj, R., Anderson, E., Rush, R., Fry, A., et al. (2004). Patient satisfaction with two different models of cancer genetic services in south-east Scotland. British Journal of Cancer, 90(3), 582–589.PubMedCrossRef
Zurück zum Zitat Meiser, B., Gaff, C., Julian-Reynier, C., Biesecker, B. B., Esplen, M. J., Vodermaier, A., et al. (2006). International perspectives on genetic counseling and testing for breast cancer risk. Breast Disease, 27, 109–125.PubMed Meiser, B., Gaff, C., Julian-Reynier, C., Biesecker, B. B., Esplen, M. J., Vodermaier, A., et al. (2006). International perspectives on genetic counseling and testing for breast cancer risk. Breast Disease, 27, 109–125.PubMed
Zurück zum Zitat Metcalfe, A., Werrett, J., Burgess, L., & Clifford, C. (2007). Psychosocial impact of the lack of information given at referral about familial risk for cancer. Psycho-Oncology, 16(5), 458–465.PubMedCrossRef Metcalfe, A., Werrett, J., Burgess, L., & Clifford, C. (2007). Psychosocial impact of the lack of information given at referral about familial risk for cancer. Psycho-Oncology, 16(5), 458–465.PubMedCrossRef
Zurück zum Zitat Michie, S., Marteau, T. M., & Bobrow, M. (1997). Genetic counselling: the psychological impact of meeting patients’ expectations. Journal of Medical Genetics, 34(3), 237–241.PubMedCrossRef Michie, S., Marteau, T. M., & Bobrow, M. (1997). Genetic counselling: the psychological impact of meeting patients’ expectations. Journal of Medical Genetics, 34(3), 237–241.PubMedCrossRef
Zurück zum Zitat Peck, B. M., Ubel, P. A., Roter, D. L., Goold, S. D., Asch, D. A., Jeffreys, A. S., et al. (2004). Do unmet expectations for specific tests, referrals, and new medications reduce patients’ satisfaction? Journal of General Internal Medicine, 19(11), 1080–1087.PubMedCrossRef Peck, B. M., Ubel, P. A., Roter, D. L., Goold, S. D., Asch, D. A., Jeffreys, A. S., et al. (2004). Do unmet expectations for specific tests, referrals, and new medications reduce patients’ satisfaction? Journal of General Internal Medicine, 19(11), 1080–1087.PubMedCrossRef
Zurück zum Zitat Pieterse, A., van Dulmen, S., Ausems, M., Schoemaker, A., Beemer, F., & Bensing, J. (2005a). QUOTE-gene(ca): development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer. Psycho-Oncology, 14(5), 361–375.CrossRef Pieterse, A., van Dulmen, S., Ausems, M., Schoemaker, A., Beemer, F., & Bensing, J. (2005a). QUOTE-gene(ca): development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer. Psycho-Oncology, 14(5), 361–375.CrossRef
Zurück zum Zitat Pieterse, A. H., Ausems, M. G., Van Dulmen, A. M., Beemer, F. A., & Bensing, J. M. (2005b). Initial cancer genetic counseling consultation: change in counselees’ cognitions and anxiety, and association with addressing their needs and preferences. American Journal of Medical Genetics. Part A, 137(1), 27–35.CrossRef Pieterse, A. H., Ausems, M. G., Van Dulmen, A. M., Beemer, F. A., & Bensing, J. M. (2005b). Initial cancer genetic counseling consultation: change in counselees’ cognitions and anxiety, and association with addressing their needs and preferences. American Journal of Medical Genetics. Part A, 137(1), 27–35.CrossRef
Zurück zum Zitat Pieterse, A. H., van Dulmen, A. M., Ausems, M. G., Beemer, F. A., & Bensing, J. M. (2005b). Communication in cancer genetic counselling: does it reflect counselees’ previsit needs and preferences? British Journal of Cancer, 92(9), 1671–1678.CrossRef Pieterse, A. H., van Dulmen, A. M., Ausems, M. G., Beemer, F. A., & Bensing, J. M. (2005b). Communication in cancer genetic counselling: does it reflect counselees’ previsit needs and preferences? British Journal of Cancer, 92(9), 1671–1678.CrossRef
Zurück zum Zitat Rao, J. K., Weinberger, M., & Kroenke, K. (2000). Visit-specific expectations and patient-centered outcomes: a literature review. Archives of Family Medicine, 9(10), 1148–1155.PubMedCrossRef Rao, J. K., Weinberger, M., & Kroenke, K. (2000). Visit-specific expectations and patient-centered outcomes: a literature review. Archives of Family Medicine, 9(10), 1148–1155.PubMedCrossRef
Zurück zum Zitat Roshanai, A. H., Rosenquist, R., Lampic, C., & Nordin, K. (2009). Does enhanced information at cancer genetic counseling improve counselees’ knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?—a randomized study. Acta Oncologica, 48(7), 999–1009.PubMedCrossRef Roshanai, A. H., Rosenquist, R., Lampic, C., & Nordin, K. (2009). Does enhanced information at cancer genetic counseling improve counselees’ knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?—a randomized study. Acta Oncologica, 48(7), 999–1009.PubMedCrossRef
Zurück zum Zitat Skinner, C. S., Schildkraut, J. M., Berry, D., Calingaert, B., Marcom, P. K., Sugarman, J., et al. (2002). Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genetic Testing, 6(2), 93–105.PubMedCrossRef Skinner, C. S., Schildkraut, J. M., Berry, D., Calingaert, B., Marcom, P. K., Sugarman, J., et al. (2002). Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genetic Testing, 6(2), 93–105.PubMedCrossRef
Zurück zum Zitat Stephenson, W. (1952). Q-methodology and the projective techniques. Journal of Clinical Psychology, 8(3), 219–229.PubMedCrossRef Stephenson, W. (1952). Q-methodology and the projective techniques. Journal of Clinical Psychology, 8(3), 219–229.PubMedCrossRef
Zurück zum Zitat Van Asperen, C. J., Van Dijk, S., Zoeteweij, M. W., Timmermans, D. R., De Bock, G. H., Meijers-Heijboer, E. J., et al. (2002). What do women really want to know? Motives for attending familial breast cancer clinics. Journal of Medical Genetics, 39(6), 410–414.PubMedCrossRef Van Asperen, C. J., Van Dijk, S., Zoeteweij, M. W., Timmermans, D. R., De Bock, G. H., Meijers-Heijboer, E. J., et al. (2002). What do women really want to know? Motives for attending familial breast cancer clinics. Journal of Medical Genetics, 39(6), 410–414.PubMedCrossRef
Zurück zum Zitat Watts, S., & Stenner, P. (2005). The subjective experience of partnership love: a Q Methodological study. The British Journal of Social Psychology, 44(Pt 1), 85–107.PubMedCrossRef Watts, S., & Stenner, P. (2005). The subjective experience of partnership love: a Q Methodological study. The British Journal of Social Psychology, 44(Pt 1), 85–107.PubMedCrossRef
Zurück zum Zitat Webler, T., Danielson, S., & Tuler, S. (2009). Using Q method to reveal social perspectives in environmental research. Social and Environmental Research Institute Webler, T., Danielson, S., & Tuler, S. (2009). Using Q method to reveal social perspectives in environmental research. Social and Environmental Research Institute
Zurück zum Zitat WHO. (2000). The World Health Report. Health system: improving peformance. Geneva: World Health Organization. WHO. (2000). The World Health Report. Health system: improving peformance. Geneva: World Health Organization.
Zurück zum Zitat Zebiene, E., Kairys, J., & Zokas, I. (2004). Influence of patient’s social and demographic characteristics on patient’s expectations for medical consultation. Medicina (Kaunas, Lithuania), 40(5), 467–474. Zebiene, E., Kairys, J., & Zokas, I. (2004). Influence of patient’s social and demographic characteristics on patient’s expectations for medical consultation. Medicina (Kaunas, Lithuania), 40(5), 467–474.
Metadaten
Titel
What Information Do Cancer Genetic Counselees Prioritize?
verfasst von
Afsaneh Hayat Roshanai
Claudia Lampic
Charlotta Ingvoldstad
Marie Stenmark Askmalm
Chathrine Bjorvatn
Richard Rosenquist
Karin Nordin
Publikationsdatum
01.08.2012
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 4/2012
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-011-9409-2

Weitere Artikel der Ausgabe 4/2012

Journal of Genetic Counseling 4/2012 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.